Fundraising FoxMartin Ventures — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Wellvana is a value-based care enablement company that operates ACOs across MSSP tracks and Medicare Advantage contracts and provides onboarding, clinical support, and the Clarity analytics platform to turn clinical, financial, and social data into care insights.
Data & InfrastructureDigital HealthHealthtechNashville, US
SCOTT LENZ(Executive Officer)IAN KYLE WAILES(Executive Officer, Director)Adam Holland(Executive Officer)in
BoardDevin Carty(Director)KAREY WITTY(Director)
Board seatCharlie Martin· per SEC Form D
Co-investorsCorewell Health VenturesFirst Trust Capital PartnersHeritage GroupOptum VenturesWhistler Capital PartnersWelsh, Carson, Anderson & Stowe
Harbor Health is a healthcare provider and insurance company operating clinics across Texas that offers primary care, specialty care, and health coaching alongside integrated insurance coverage.
HealthtechInsurTechAustin, US
Sterling Claiborne Johnston(Chief Medical Officer)Jeffrey Fisher(Chief Financial Officer)Eric Scott(Vice President)inKara Rios(Chief Financial Officer)inClay Johnston(Founder)Tony Miller(Founder)
Co-investors8VCAlta PartnersCubit CapitalGeneral CatalystHealth2047 Capital Partners LLCLemhi Ventures+2 more
.png)
Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.
AI & Machine LearningDigital HealthHealthtechChicago, US
Peter Wallach(Co-Founder, Life Sciences)Brian Wallach(Co-Founder, Board Co-Chair)inMartina de Majo(Founder)inSandra Abrevaya(Co-Founder, Chief Executive Officer)inJason Langheier(Co-Founder, Board Co-Chair)inJaimie Hatcher-Martin(Dr.)
Co-investorsGeneral AtlanticSV AngelB Capital GroupB4 CapitalBeaconsfield CapitalCVS Health Ventures+15 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.